As previously reported, the College is committed to helping you — our members — make sense of a medical world that is increasingly influenced by artificial (or augmented) intelligence and the various tools and applications powered by AI. In addition, we are committed to exploring the best and most beneficial uses of these tools to enhance member value. This includes not only our production of valuable resources, but also how our members discover and use the many benefits the College offers.
As you are no doubt aware, there are many promising use cases with the potential to improve workflow, diagnostics, and many other aspects of patient care. Like most health care organizations, we understand that AI comes with benefits as well as risks, and we are poised to help our members both benefit from new tools as well as be prepared for challenges posed by this rapidly evolving technology.
Adapting to — and thriving in — this changing world requires expertise as well as vigilance. The College has been proactively researching, responding to, and navigating this area for some time, with many articles published in previous issues of College Insider.
Among our most recent activities is our participation with 20 other medical societies in the AMA AI Specialty Collaborative, a consortium dedicated to evaluate and help physicians understand the burgeoning availability of AI-enhanced tools for practice. The Collaborative’s AI Evaluation Guide equips allergists with practical tools and a framework to evaluate AI applications, ensure patient safety, and make informed decisions — without needing deep technical expertise.
You may also have seen the College’s excellent, nuts and bolts webinar Practical Artificial Intelligence for Allergists, with a focus on in-office documentation, administrative support, and revenue cycle management. It’s available on demand on our College Learning Connection. An earlier webinar, Artificial Intelligence for Allergists, explores use cases, potential benefits, and risk mitigation. These are free to members, and I encourage you to take a look.
Here are a few more examples of how the College is effectively assimilating, analyzing and planning for the continuing challenges of AI:
- The College has appointed an AI and Technology Subcommittee (chaired by Fatima Khan, MD, FACAAI) to assess artificial/augmented intelligence and technology needs for allergy practices. The subcommittee was conceived in early 2025 and ratified by the Board of Regents in June 2025. It also explores how allergy practices can use these tools safely and productively to improve practice efficiency and patient engagement. Additionally, the subcommittee develops resources and information to assist practices with evaluating and implementing these technologies.
- We will continue to monitor health care regulations as we do for other forms of technology, so that we can advocate on your behalf.
- We are monitoring and addressing inappropriate AI-powered claim denials.
- We are supporting research projects related to use of AI through our Community Grant Program.
- Our Annals of Allergy, Asthma & Immunology editors and publisher have processes and tools in place to evaluate submitted manuscripts for legitimacy in the face of increased use of AI for creating articles.
- AI will allow us to further customize and personalize the experience of our members in accessing and using the myriad resources we offer. Providing this experience in an optimal and ethical manner is a priority.
- We are learning from leading experts in the association and IT spheres to optimize how we use AI and information in a way that respects data privacy and intellectual property, and that protects the College’s valuable assets.
- We are actively working to apply AI to more efficiently create and update our incredibly popular practice tools.
- AI and technology will be among the highlights of our 2026 Annual Scientific Meeting program and will be hot topics in our strategic planning activities as we look to the next several years.
AI is moving quickly, and we are right where we should be to harness the positives and help counter the negatives. We are fortunate to have many forward-thinking and experienced board members, volunteers and staff who are actively planning for the future and lending their expertise to the above-mentioned projects and several others in the works.
It’s exciting to be on the cutting edge of helping allergists adapt and benefit from AI, while also protecting your interests and remaining vigilant to the downsides and inappropriate uses of the technology. The leadership of the College will continue to keep you updated on our activities in this area.
